| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | phosphatidylserine exposure on apoptotic cell surface | 1.71e-07 | 12 | 20 | 3 | GO:0070782 | |
| GeneOntologyBiologicalProcess | engulfment of apoptotic cell | 3.52e-07 | 15 | 20 | 3 | GO:0043652 | |
| GeneOntologyBiologicalProcess | plasma membrane phospholipid scrambling | 2.00e-06 | 26 | 20 | 3 | GO:0017121 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in development | 1.23e-05 | 47 | 20 | 3 | GO:1902742 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 1.31e-05 | 48 | 20 | 3 | GO:0043277 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 1.98e-05 | 55 | 20 | 3 | GO:0045332 | |
| GeneOntologyBiologicalProcess | lipid translocation | 2.58e-05 | 60 | 20 | 3 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 3.28e-05 | 65 | 20 | 3 | GO:0097035 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 3.92e-05 | 69 | 20 | 3 | GO:0006911 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 5.66e-05 | 78 | 20 | 3 | GO:0099024 | |
| GeneOntologyBiologicalProcess | membrane invagination | 7.85e-05 | 87 | 20 | 3 | GO:0010324 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 1.41e-04 | 106 | 20 | 3 | GO:0015914 | |
| GeneOntologyBiologicalProcess | execution phase of apoptosis | 1.49e-04 | 108 | 20 | 3 | GO:0097194 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 4.91e-04 | 162 | 20 | 3 | GO:0015748 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine morphogenesis | 4.92e-04 | 34 | 20 | 2 | GO:0061003 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 7.23e-04 | 185 | 20 | 3 | GO:0099175 | |
| GeneOntologyBiologicalProcess | plasma membrane organization | 7.58e-04 | 188 | 20 | 3 | GO:0007009 | |
| GeneOntologyBiologicalProcess | regulation of programmed necrotic cell death | 7.88e-04 | 43 | 20 | 2 | GO:0062098 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine morphogenesis | 1.74e-03 | 64 | 20 | 2 | GO:0061001 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 1.90e-03 | 67 | 20 | 2 | GO:0050775 | |
| GeneOntologyBiologicalProcess | programmed necrotic cell death | 1.96e-03 | 68 | 20 | 2 | GO:0097300 | |
| GeneOntologyBiologicalProcess | polyol biosynthetic process | 2.02e-03 | 69 | 20 | 2 | GO:0046173 | |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 2.02e-03 | 69 | 20 | 2 | GO:0010770 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 2.07e-03 | 70 | 20 | 2 | GO:0060999 | |
| GeneOntologyBiologicalProcess | phagocytosis | 2.24e-03 | 274 | 20 | 3 | GO:0006909 | |
| HumanPheno | Irritability | 3.98e-05 | 275 | 5 | 4 | HP:0000737 | |
| Domain | XK_rel | 1.72e-07 | 11 | 20 | 3 | IPR018629 | |
| Domain | XK-related | 1.72e-07 | 11 | 20 | 3 | PF09815 | |
| Pubmed | Exposure of phosphatidylserine by Xk-related protein family members during apoptosis. | 2.27e-08 | 10 | 21 | 3 | 25231987 | |
| Pubmed | 2.97e-04 | 549 | 21 | 4 | 38280479 | ||
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 4.64e-04 | 254 | 21 | 3 | 28431233 | |
| Pubmed | Common variants at 30 loci contribute to polygenic dyslipidemia. | 4.88e-04 | 54 | 21 | 2 | 19060906 | |
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 5.43e-04 | 57 | 21 | 2 | 17932509 | |
| Pubmed | 5.79e-04 | 274 | 21 | 3 | 34244482 | ||
| GeneFamily | Blood group antigens|XK related family | 4.78e-08 | 11 | 13 | 3 | 955 | |
| ToppCell | Severe-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.88e-05 | 111 | 21 | 3 | 7021009545178fac1f19f3c429bfedb2f38b680d | |
| ToppCell | Severe-B_intermediate-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.75e-05 | 126 | 21 | 3 | 42a0bdbe18ef85146cac4e86b2b27d0b3b20d8a2 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.38e-05 | 135 | 21 | 3 | 7743a01dc9c4542e910e7c0fe046004692a680bf | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.09e-05 | 144 | 21 | 3 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | Tuft-tuft-3|World / Class top | 4.44e-05 | 148 | 21 | 3 | f4f59b46a79fc9aa4c5d330a7b37b1a34a6d71cc | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 157 | 21 | 3 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.39e-05 | 158 | 21 | 3 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.71e-05 | 161 | 21 | 3 | bd520c9a1927d5d5355b4421e6b90b58bfb76a42 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.03e-05 | 164 | 21 | 3 | 057ca87847373eff7fe97dd9f4358509e66ca4c3 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.36e-05 | 167 | 21 | 3 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.81e-05 | 179 | 21 | 3 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | 15-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 7.94e-05 | 180 | 21 | 3 | 99e2db9ad8e09fedc3542233553acece69f579f1 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 8.21e-05 | 182 | 21 | 3 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.21e-05 | 182 | 21 | 3 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.21e-05 | 182 | 21 | 3 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.34e-05 | 183 | 21 | 3 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 8.61e-05 | 185 | 21 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 9.03e-05 | 188 | 21 | 3 | 0e8ac42c439f30a05e015210e1d5c2dcb9d9d471 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 198 | 21 | 3 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.07e-04 | 199 | 21 | 3 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.07e-04 | 199 | 21 | 3 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.07e-04 | 199 | 21 | 3 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.07e-04 | 199 | 21 | 3 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Neuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 21 | 3 | a581f1704a87b0390e1e2ff85053367d85247755 | |
| Computational | Genes in the cancer module 568. | 1.24e-03 | 73 | 8 | 2 | MODULE_568 | |
| Computational | Genes in the cancer module 491. | 1.45e-03 | 79 | 8 | 2 | MODULE_491 | |
| Disease | lip morphology measurement | 3.16e-04 | 189 | 21 | 3 | EFO_0007845 | |
| Disease | osteoarthritis | 5.06e-04 | 222 | 21 | 3 | MONDO_0005178 | |
| Disease | corpus callosum posterior volume measurement | 6.26e-04 | 52 | 21 | 2 | EFO_0010298 | |
| Disease | endometriosis | 7.31e-04 | 252 | 21 | 3 | EFO_0001065 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.70e-03 | 86 | 21 | 2 | EFO_0008595, EFO_0020945 | |
| Disease | fatty acid measurement | 3.50e-03 | 436 | 21 | 3 | EFO_0005110 | |
| Disease | hemorrhoid | 4.86e-03 | 147 | 21 | 2 | EFO_0009552 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.26e-03 | 153 | 21 | 2 | EFO_0004611, EFO_0020944 | |
| Disease | body fat distribution | 8.99e-03 | 202 | 21 | 2 | EFO_0004341 | |
| Disease | neutrophil count, eosinophil count | 9.95e-03 | 213 | 21 | 2 | EFO_0004833, EFO_0004842 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.01e-02 | 215 | 21 | 2 | EFO_0008317, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.06e-02 | 220 | 21 | 2 | EFO_0004529, EFO_0008317 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.10e-02 | 224 | 21 | 2 | EFO_0004530, EFO_0008317 | |
| Disease | neutrophil count, basophil count | 1.10e-02 | 224 | 21 | 2 | EFO_0004833, EFO_0005090 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.10e-02 | 224 | 21 | 2 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.10e-02 | 225 | 21 | 2 | EFO_0008317, EFO_0010351 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.14e-02 | 229 | 21 | 2 | EFO_0004639, EFO_0008317 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAERRKREEHQRWYE | 1406 | P55196 | |
| PGYDIRDWELRKIHR | 26 | Q8IVF6 | |
| LRQRPEWDKHYRSVE | 446 | Q8WXI4 | |
| YDRWKHPFFLDDRRT | 321 | Q13510 | |
| RDDRWSDDHYEREKR | 266 | Q96F81 | |
| YRVPRDDWEEKRHFR | 171 | P43243 | |
| VDFRDPFEKERYREW | 816 | Q7Z6E9 | |
| PFEKERYREWERKYR | 821 | Q7Z6E9 | |
| YLPHWERSSRDREEK | 16 | Q8TAB7 | |
| EKYWRDPEVFHPERF | 411 | Q6VVX0 | |
| WEEARRRGFRYEKDY | 766 | Q9H2U1 | |
| AKRARQEFPWEEEYR | 791 | Q9NSG2 | |
| DRKPHYDRRASEIDW | 131 | B2RV13 | |
| APEHYERRELIRRTW | 126 | Q6ZMB0 | |
| WYETDPRRHKESCER | 31 | Q8NBL3 | |
| RYFAHRRAWEDAEKD | 1101 | O14594 | |
| YDQEKRDLPWRRRAE | 101 | Q9UIF7 | |
| PDRRHELYKAHEWAR | 341 | Q12765 | |
| RKRYPAWDAHFVDRR | 591 | Q5GH73 | |
| KYPAWDAHFIDRRLR | 531 | Q5GH72 | |
| KIDLFRNRYPAWERH | 596 | Q5GH76 | |
| QPERAWVHEKRVREY | 316 | Q9BZ95 | |
| RKRHREQYDVPQEWR | 5406 | Q9UKN1 |